Bionano Genomics, Inc. Operating Lease, Expense
Bionano Genomics, Inc. (BNGO) reported Operating Lease, Expense of $2.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-03-23
- Bionano Genomics, Inc. operating lease, expense for the quarter ending 2022-12-31 was $1.95M, a 176.56% increase year-over-year.
- Bionano Genomics, Inc. operating lease, expense for the quarter ending 2022-09-30 was $500.00K, a 66.67% increase year-over-year.
- Bionano Genomics, Inc. operating lease, expense for the quarter ending 2022-06-30 was $500.00K, a 66.67% increase year-over-year.
- Bionano Genomics, Inc. operating lease, expense for the quarter ending 2022-03-31 was $500.00K, a 150.00% increase year-over-year.
- Bionano Genomics, Inc. operating lease, expense for fiscal 2025 was $2.50M, a 33.40% decline from fiscal 2024.
- Bionano Genomics, Inc. operating lease, expense for fiscal 2024 was $3.75M, a 0.64% decline from fiscal 2023.
- Bionano Genomics, Inc. operating lease, expense for fiscal 2023 was $3.78M, a 9.60% increase from fiscal 2022.
- Bionano Genomics, Inc. operating lease, expense for fiscal 2022 was $3.45M, a 129.19% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $2.50M 10-K · filed 2026-03-23 | ||||
| 2024-12-31 | $3.75M 10-K · filed 2026-03-23 | ||||
| 2023-12-31 | $3.78M 10-K · filed 2025-03-31 | ||||
| 2022-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $2.45M derived: sum of 2 quarters · filed 2024-03-05 | $2.95M derived: sum of 3 quarters · filed 2024-03-05 | $3.45M 10-K · filed 2024-03-05 | $3.02M 10-K · filed 2023-03-09 |
| 2022-09-30 | $500.00K 10-Q · filed 2022-11-03 | $1.00M derived: sum of 2 quarters · filed 2022-11-03 | $1.50M 10-Q · filed 2022-11-03 | $2.20M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2022-06-30 | $500.00K 10-Q · filed 2022-08-04 | $1.00M 10-Q · filed 2022-08-04 | $1.70M derived: sum of 3 quarters · filed 2023-03-09 | $2.00M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2022-03-31 | $500.00K 10-Q · filed 2022-05-05 | $1.20M derived: sum of 2 quarters · filed 2023-03-09 | $1.50M derived: sum of 3 quarters · filed 2023-03-09 | $1.80M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-12-31 | $704.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.00M derived: sum of 2 quarters · filed 2023-03-09 | $1.30M derived: sum of 3 quarters · filed 2023-03-09 | $1.50M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-03 | $600.00K derived: sum of 2 quarters · filed 2022-11-03 | $800.00K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-04 | $500.00K 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | $887.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |